Spironolactone for PCOS: Role in Treatment
Primary Role: Antiandrogen Therapy for Hirsutism and Acne
Spironolactone is an effective antiandrogen agent for treating hirsutism and acne in women with PCOS, typically dosed at 50-200 mg daily, and works best when combined with oral contraceptives for menstrual regulation and pregnancy prevention. 1, 2
Mechanism and Efficacy
- Spironolactone decreases testosterone production and competitively inhibits testosterone and dihydrotestosterone binding to androgen receptors in the skin 1, 2
- It may also inhibit 5α-reductase and increase sex hormone-binding globulin 1, 2
- For hirsutism specifically, spironolactone (100 mg/day) shows superior efficacy compared to finasteride and cyproterone acetate in idiopathic hirsutism, though results are more variable in PCOS patients 3
- In PCOS patients, spironolactone 50 mg daily significantly reduces hirsutism scores from baseline (12.9 to 8.7 at 6 months) and improves menstrual cyclicity 4
Optimal Treatment Strategy
The combination of spironolactone with oral contraceptives is more effective than either agent alone for managing PCOS-related hyperandrogenism 5:
- Oral contraceptives suppress ovarian androgen production while spironolactone blocks peripheral androgen effects 5
- This combination addresses both the source and the target-organ effects of excess androgens 5
- Concomitant use of spironolactone with drospirenone-containing oral contraceptives does not increase hyperkalemia risk or adverse effects requiring discontinuation 1, 2
Dosing Considerations
- Start with 50-100 mg daily for most patients, as lower doses (50 mg) show comparable efficacy to metformin for hirsutism with fewer adverse events 4
- Higher doses up to 200 mg daily can be used for refractory cases, though side effects are dose-dependent 1, 6
- Clinical improvement in hirsutism takes 3-6 months to become apparent 4
Metabolic Effects: Limited but Potentially Beneficial
Insulin Resistance and Metabolic Parameters
- Spironolactone 50 mg daily shows no significant difference compared to metformin alone on insulin resistance (HOMA-IR), FSH, LH, BMI, or menstrual cyclicity 3, 4
- However, combining low-dose spironolactone (25 mg) with metformin produces greater reduction in HOMA-IR than either drug alone (1.71 vs 1.92 for metformin alone, P<0.05) 7
- The combination of metformin plus low-dose spironolactone (25 mg) induces more marked reduction of clinical and biochemical hyperandrogenism than metformin alone 8
Hormonal Effects
- Spironolactone reduces serum testosterone and androstenedione levels in PCOS patients 4
- It decreases LH/FSH ratio, though less effectively than cyproterone acetate combined with estrogen 6
- Dehydroepiandrosterone sulfate (DHEA-S) decreases more significantly when spironolactone is combined with metformin 8
Safety Profile and Monitoring
Common Side Effects
- Menstrual irregularities (22-40%) are the most common side effect, which are dose-dependent and less common when combined with oral contraceptives 1, 2, 3
- Diuresis (29%), breast tenderness (17%), breast enlargement, fatigue, headache, and dizziness occur in a dose-related manner 1
- Mild nausea, vomiting, and diarrhea may occur but are generally well-tolerated 3
Contraindications and Precautions
- Spironolactone is pregnancy category C due to risk of feminization of male fetuses; concomitant oral contraceptive use is strongly recommended in sexually active women 1
- Hyperkalemia is rare in young healthy individuals with no renal impairment 1
- Potassium monitoring should be considered in older patients, those with comorbidities (hypertension, diabetes, chronic kidney disease), and those taking medications affecting renal/adrenal function (ACE inhibitors, ARBs, NSAIDs) 2
Clinical Algorithm for Use
When to Use Spironolactone
- First-line for hirsutism and acne in women with PCOS not attempting to conceive 5
- Always combine with oral contraceptives for optimal efficacy and pregnancy prevention 1, 5
- Consider adding low-dose spironolactone (25 mg) to metformin if metabolic therapy alone inadequately controls hyperandrogenic symptoms 8
When NOT to Use as Monotherapy
- In PCOS patients attempting to conceive (use clomiphene citrate instead) 9, 5
- As sole therapy for metabolic dysfunction (lifestyle modification and metformin are superior) 9, 10
- For menstrual regulation alone (oral contraceptives are first-line) 5
Important Caveats
- Spironolactone is not FDA-approved for PCOS or acne treatment; this is off-label use 1, 2
- Treatment addresses symptoms (hirsutism, acne) rather than underlying PCOS pathophysiology 11
- For idiopathic hirsutism, spironolactone as monotherapy is as effective as cyproterone acetate combined with estradiol, but in PCOS patients, combination therapy is necessary for optimal hormonal and metabolic management 6
- Clinical response requires 3-6 months; patients should be counseled about delayed onset of action 4